BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 23340377)

  • 1. Sexual dimorphisms and prediction of conversion in the NAPLS psychosis prodrome.
    Walder DJ; Holtzman CW; Addington J; Cadenhead K; Tsuang M; Cornblatt B; Cannon TD; McGlashan TH; Woods SW; Perkins DO; Seidman LJ; Heinssen R; Walker EF
    Schizophr Res; 2013 Mar; 144(1-3):43-50. PubMed ID: 23340377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Machine Learning to Determine Deviance in Neuroanatomical Maturity Associated With Future Psychosis in Youths at Clinically High Risk.
    Chung Y; Addington J; Bearden CE; Cadenhead K; Cornblatt B; Mathalon DH; McGlashan T; Perkins D; Seidman LJ; Tsuang M; Walker E; Woods SW; McEwen S; van Erp TGM; Cannon TD;
    JAMA Psychiatry; 2018 Sep; 75(9):960-968. PubMed ID: 29971330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis.
    Seidman LJ; Giuliano AJ; Meyer EC; Addington J; Cadenhead KS; Cannon TD; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; Bearden CE; Christensen BK; Hawkins K; Heaton R; Keefe RS; Heinssen R; Cornblatt BA;
    Arch Gen Psychiatry; 2010 Jun; 67(6):578-88. PubMed ID: 20530007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study.
    Seidman LJ; Shapiro DI; Stone WS; Woodberry KA; Ronzio A; Cornblatt BA; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW
    JAMA Psychiatry; 2016 Dec; 73(12):1239-1248. PubMed ID: 27806157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Profiles and Conversion Rates Among Young Individuals With Autism Spectrum Disorder Who Present to Clinical High Risk for Psychosis Services.
    Foss-Feig JH; Velthorst E; Smith L; Reichenberg A; Addington J; Cadenhead KS; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Stone WS; Keshavan M; Tsuang MT; Walker EF; Woods SW; Cannon TD; Bearden CE
    J Am Acad Child Adolesc Psychiatry; 2019 Jun; 58(6):582-588. PubMed ID: 30797038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms.
    Addington J; Liu L; Buchy L; Cadenhead KS; Cannon TD; Cornblatt BA; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; McGlashan TH
    J Nerv Ment Dis; 2015 May; 203(5):328-35. PubMed ID: 25919383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression and clinical high-risk states: Baseline presentation of depressed vs. non-depressed participants in the NAPLS-2 cohort.
    Kline ER; Seidman LJ; Cornblatt BA; Woodberry KA; Bryant C; Bearden CE; Cadenhead KS; Cannon TD; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; Addington J
    Schizophr Res; 2018 Feb; 192():357-363. PubMed ID: 28578922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized Prediction of Psychosis: External Validation of the NAPLS-2 Psychosis Risk Calculator With the EDIPPP Project.
    Carrión RE; Cornblatt BA; Burton CZ; Tso IF; Auther AM; Adelsheim S; Calkins R; Carter CS; Niendam T; Sale TG; Taylor SF; McFarlane WR
    Am J Psychiatry; 2016 Oct; 173(10):989-996. PubMed ID: 27363511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Global Functioning: Social and Role Scales-Further Validation in a Large Sample of Adolescents and Young Adults at Clinical High Risk for Psychosis.
    Carrión RE; Auther AM; McLaughlin D; Olsen R; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Cornblatt BA
    Schizophr Bull; 2019 Jun; 45(4):763-772. PubMed ID: 30351423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adolescents at clinical-high risk for psychosis: Circadian rhythm disturbances predict worsened prognosis at 1-year follow-up.
    Lunsford-Avery JR; Gonçalves BDSB; Brietzke E; Bressan RA; Gadelha A; Auerbach RP; Mittal VA
    Schizophr Res; 2017 Nov; 189():37-42. PubMed ID: 28169087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of violent behaviour in young people at clinical high risk for psychosis from the North American Prodrome Longitudinal Studies consortium.
    Tronick LN; Mirzakhanian H; Addington J; Bearden CE; Cannon TD; Cornblatt BA; Keshavan M; Mathalon DH; McGlashan TH; Perkins DO; Stone W; Tsuang MT; Walker EF; Woods SW; Cadenhead KS
    Early Interv Psychiatry; 2023 Aug; 17(8):759-770. PubMed ID: 36627192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premorbid functional development and conversion to psychosis in clinical high-risk youths.
    Tarbox SI; Addington J; Cadenhead KS; Cannon TD; Cornblatt BA; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Heinssen R; McGlashan TH; Woods SW
    Dev Psychopathol; 2013 Nov; 25(4 Pt 1):1171-86. PubMed ID: 24229556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative symptoms and impaired social functioning predict later psychosis in Latino youth at clinical high risk in the North American prodromal longitudinal studies consortium.
    Alderman T; Addington J; Bearden C; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Cadenhead KS
    Early Interv Psychiatry; 2015 Dec; 9(6):467-75. PubMed ID: 24576057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion.
    Zhang TH; Li HJ; Woodberry KA; Xu LH; Tang YY; Guo Q; Cui HR; Liu XH; Chow A; Li CB; Jiang KD; Xiao ZP; Seidman LJ; Wang JJ
    Epidemiol Psychiatr Sci; 2017 Jun; 26(3):287-298. PubMed ID: 27056022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline demographics, clinical features and predictors of conversion among 200 individuals in a longitudinal prospective psychosis-risk cohort.
    Brucato G; Masucci MD; Arndt LY; Ben-David S; Colibazzi T; Corcoran CM; Crumbley AH; Crump FM; Gill KE; Kimhy D; Lister A; Schobel SA; Yang LH; Lieberman JA; Girgis RR
    Psychol Med; 2017 Aug; 47(11):1923-1935. PubMed ID: 28249639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortical abnormalities in youth at clinical high-risk for psychosis: Findings from the NAPLS2 cohort.
    Chung Y; Allswede D; Addington J; Bearden CE; Cadenhead K; Cornblatt B; Mathalon DH; McGlashan T; Perkins D; Seidman LJ; Tsuang M; Walker E; Woods SW; McEwen S; van Erp TGM; Cannon TD;
    Neuroimage Clin; 2019; 23():101862. PubMed ID: 31150956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocognitive profiles in the prodrome to psychosis in NAPLS-1.
    Velthorst E; Meyer EC; Giuliano AJ; Addington J; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; Bearden CE; Seidman LJ
    Schizophr Res; 2019 Feb; 204():311-319. PubMed ID: 30078717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sleep Disturbance in Individuals at Clinical High Risk for Psychosis.
    Zaks N; Velikonja T; Parvaz MA; Zinberg J; Done M; Mathalon DH; Addington J; Cadenhead K; Cannon T; Cornblatt B; McGlashan T; Perkins D; Stone WS; Tsuang M; Walker E; Woods SW; Keshavan MS; Buysse DJ; Velthorst E; Bearden CE
    Schizophr Bull; 2022 Jan; 48(1):111-121. PubMed ID: 34536012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of premorbid functioning in individuals at clinical high risk of psychosis.
    Lyngberg K; Buchy L; Liu L; Perkins D; Woods S; Addington J
    Schizophr Res; 2015 Dec; 169(1-3):209-213. PubMed ID: 26589390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex- and Age-Specific Deviations in Cerebellar Structure and Their Link With Symptom Dimensions and Clinical Outcome in Individuals at Clinical High Risk for Psychosis.
    Sefik E; Boamah M; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Keshavan MS; Mathalon DH; Perkins DO; Stone WS; Tsuang MT; Woods SW; Cannon TD; Walker EF
    Schizophr Bull; 2023 Mar; 49(2):350-363. PubMed ID: 36394426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.